B
ETON icon

Bailard’s Eton Pharmaceutcials ETON Stock Holding History

Bailard’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-22,639
Closed -$99.2K – 761
2023
Q4 		$99.2K Buy
+22,639
New +$90.8K ﹤0.01% 694
2023
Q3 		– Sell
-12,700
Closed -$44.3K – 728
2023
Q2 		$44.3K Buy
+12,700
New +$46.7K ﹤0.01% 679

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.43M AUM 17.52% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Bailard's ETON Position: Q1 2024 in Review

Bailard sold out of Eton Pharmaceutcials (ETON) in Q1 2024, closing a stake of 22,639 shares — an estimated $99.2K sold.

Bailard first reported a position in ETON in Q2 2023 and held it in 2 quarters. The position peaked at $99.2K in Q4 2023. 44 funds tracked by Wall St. Rank hold ETON as of Q1 2024.

  • Bailard reported no remaining Eton Pharmaceutcials position as of Q1 2024 after selling out during the quarter.
  • Bailard sold 22,639 Eton Pharmaceutcials shares in Q1 2024, an estimated $99.2K.
  • Bailard first reported a position in Eton Pharmaceutcials in Q2 2023 and held it in 2 quarters.
  • Bailard's Eton Pharmaceutcials position peaked at $99.2K in Q4 2023.
  • 44 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2024.

Based on Bailard's 13F filing for Q1 2024, filed 8 May 2024.